Similarly, IL1RAP genetic variants correlate with accelerated amyloid accumulation, elevated cerebrospinal fluid (CSF) tau, and cognitive decline in AD cohorts (Zettergren et al., 2019; Ramanan et al., 2015), further implicating inflammatory pathways in disease progression. Here, MAPT is linked to Alzheimer disease.